Diabetic Macular Oedema Central Macular Thickness Threshold

Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol

Each component has a specific meaning:

  • Central macular thickness — The central macular thickness recorded for the scenario being assessed.
  • BCVA — The bcva recorded for the scenario being assessed.
  • Anti-VEGF injection interval optimization — The anti-vegf injection interval optimization recorded for the scenario being assessed.

Note: Interpret the dme cmt threshold result against the thresholds and context described above.

How to Use

Enter the central macular thickness, BCVA, anti-VEGF injection interval optimization for the scenario you are assessing. Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol. Use the dme cmt threshold result to inform your calculation.

Frequently Asked Questions